These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 18682456)

  • 1. Predictors of 30-day mortality and hospital costs in patients with ventilator-associated pneumonia attributed to potentially antibiotic-resistant gram-negative bacteria.
    Kollef KE; Schramm GE; Wills AR; Reichley RM; Micek ST; Kollef MH
    Chest; 2008 Aug; 134(2):281-287. PubMed ID: 18682456
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Empiric antibiotics pending bronchoalveolar lavage data in patients without pneumonia significantly alters the flora, but not the resistance profile, if a subsequent pneumonia develops.
    Thakkar RK; Monaghan SF; Adams CA; Stephen A; Connolly MD; Gregg S; Cioffi WG; Heffernan DS
    J Surg Res; 2013 May; 181(2):323-8. PubMed ID: 22906560
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The influence of mini-BAL cultures on patient outcomes: implications for the antibiotic management of ventilator-associated pneumonia.
    Kollef MH; Ward S
    Chest; 1998 Feb; 113(2):412-20. PubMed ID: 9498961
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hospital-acquired pneumonia and ventilator-associated pneumonia in adults at Siriraj Hospital: etiology, clinical outcomes, and impact of antimicrobial resistance.
    Werarak P; Kiratisin P; Thamlikitkul V
    J Med Assoc Thai; 2010 Jan; 93 Suppl 1():S126-38. PubMed ID: 20364567
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Length of stay and hospital costs associated with a pharmacodynamic-based clinical pathway for empiric antibiotic choice for ventilator-associated pneumonia.
    Nicasio AM; Eagye KJ; Kuti EL; Nicolau DP; Kuti JL
    Pharmacotherapy; 2010 May; 30(5):453-62. PubMed ID: 20411997
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of adjunctive aerosolized antimicrobial therapy in the treatment of Pseudomonas aeruginosa and Acinetobacter baumannii ventilator-associated pneumonia.
    Arnold HM; Sawyer AM; Kollef MH
    Respir Care; 2012 Aug; 57(8):1226-33. PubMed ID: 22349038
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Novel Algorithm to Analyze Epidemiology and Outcomes of Carbapenem Resistance Among Patients With Hospital-Acquired and Ventilator-Associated Pneumonia: A Retrospective Cohort Study.
    Zilberberg MD; Nathanson BH; Sulham K; Fan W; Shorr AF
    Chest; 2019 Jun; 155(6):1119-1130. PubMed ID: 30685333
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early predictors for infection recurrence and death in patients with ventilator-associated pneumonia.
    Combes A; Luyt CE; Fagon JY; Wolff M; Trouillet JL; Chastre J
    Crit Care Med; 2007 Jan; 35(1):146-54. PubMed ID: 17080004
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of pathogen-directed antimicrobial therapy for ventilator-associated pneumonia in trauma patients on charges and recurrence.
    Sharpe JP; Magnotti LJ; Weinberg JA; Swanson JM; Wood GC; Fabian TC; Croce MA
    J Am Coll Surg; 2015 Apr; 220(4):489-95. PubMed ID: 25572796
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Duration of antibiotic therapy for ventilator-associated pneumonia caused by non-fermentative gram-negative bacilli.
    Hedrick TL; McElearney ST; Smith RL; Evans HL; Pruett TL; Sawyer RG
    Surg Infect (Larchmt); 2007 Dec; 8(6):589-97. PubMed ID: 18171118
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk factors for relapse of ventilator-associated pneumonia related to nonfermenting Gram negative bacilli: a case-control study.
    Nseir S; Deplanque X; Di Pompeo C; Diarra M; Roussel-Delvallez M; Durocher A
    J Infect; 2008 May; 56(5):319-25. PubMed ID: 18405975
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stenotrophomonas maltophilia ventilator-associated pneumonia. A retrospective matched case-control study.
    Scholte JB; Zhou TL; Bergmans DC; Rohde GG; Winkens B; Van Dessel HA; Dormans TP; Linssen CF; Roekaerts PM; Savelkoul PH; van Mook WN
    Infect Dis (Lond); 2016 Oct; 48(10):738-43. PubMed ID: 27207483
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Does de-escalation of antibiotic therapy for ventilator-associated pneumonia affect the likelihood of recurrent pneumonia or mortality in critically ill surgical patients?
    Eachempati SR; Hydo LJ; Shou J; Barie PS
    J Trauma; 2009 May; 66(5):1343-8. PubMed ID: 19430237
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reinventing the wheel: Impact of prolonged antibiotic exposure on multidrug-resistant ventilator-associated pneumonia in trauma patients.
    Lewis RH; Sharpe JP; Swanson JM; Fabian TC; Croce MA; Magnotti LJ
    J Trauma Acute Care Surg; 2018 Aug; 85(2):256-262. PubMed ID: 29664891
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Causative pathogen dictates optimal duration of antimicrobial therapy for ventilator-associated pneumonia in trauma patients.
    Magnotti LJ; Croce MA; Zarzaur BL; Swanson JM; Wood GC; Weinberg JA; Fabian TC
    J Am Coll Surg; 2011 Apr; 212(4):476-84; discussion 484-6. PubMed ID: 21463773
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment of recurrent Stenotrophomonas maltophilia ventilator-associated pneumonia with doxycycline and aerosolized colistin.
    Wood GC; Underwood EL; Croce MA; Swanson JM; Fabian TC
    Ann Pharmacother; 2010 Oct; 44(10):1665-8. PubMed ID: 20736426
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The pathogen of ventilator-associated pneumonia does not influence the mortality rate of surgical intensive care unit patients treated with a rotational antibiotic system.
    Eachempati SR; Hydo LJ; Shou J; Barie PS
    Surg Infect (Larchmt); 2010 Feb; 11(1):13-20. PubMed ID: 20163258
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Integrating rapid diagnostics and antimicrobial stewardship improves outcomes in patients with antibiotic-resistant Gram-negative bacteremia.
    Perez KK; Olsen RJ; Musick WL; Cernoch PL; Davis JR; Peterson LE; Musser JM
    J Infect; 2014 Sep; 69(3):216-25. PubMed ID: 24841135
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The impact of an antibiotic cycling program on empirical therapy for gram-negative infections.
    Merz LR; Warren DK; Kollef MH; Fridkin SK; Fraser VJ
    Chest; 2006 Dec; 130(6):1672-8. PubMed ID: 17166981
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of aerosolized aminoglycosides in the treatment of Gram-negative ventilator-associated pneumonia.
    Mohr AM; Sifri ZC; Horng HS; Sadek R; Savetamal A; Hauser CJ; Livingston DH
    Surg Infect (Larchmt); 2007 Jun; 8(3):349-57. PubMed ID: 17635058
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.